Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Gustave Roussy at ASCO 2023
Gustave Roussy's Key Presentations at the 2023 ASCO Annual Meeting.
Gustave Roussy is participating in the largest annual cancer conference organized by the American Society of Clinical Oncology (ASCO) from June 2 to 6, 2023. This major event showcases the latest innovations and clinical research findings in oncology.
This year, approximately 50 presentations will be delivered by physician-researchers from Gustave Roussy, featuring studies that offer new therapeutic strategies to benefit patients.
Biomarkers Predicting the Efficacy of Targeted Dual Therapy in Metastatic Lung Cancer with EGFR Mutations
The BIOMEDE study standardizes molecular profiling to guide diagnosis and management of infiltrating brainstem glioma
► Video explanation:
This video is hosted by YouTube. To view it on our website, you must enable cookies.
Accept cookies
Metastatic prostate cancer with DNA repair gene mutations: a highly promising combination of hormone therapy and a PARP inhibitor
► Video explanation:
This video is hosted by YouTube. To play it on our website, you must enable cookies.
Accept cookies
Benefits of radiation therapy combined with abiraterone and standard treatment in patients with minimally metastatic prostate cancer
► Video explanation:
This video is hosted by YouTube. To play it on our website, you must enable cookies.
Accept cookies
Urinary Tract Cancers – Evidence of the Superiority of Targeted Therapy Over Standard Treatment
► Video explanation:
This video is hosted by YouTube. To play it on our website, you must enable cookies.
Accept cookies